{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T07:07:09Z","timestamp":1778310429770,"version":"3.51.4"},"reference-count":75,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T00:00:00Z","timestamp":1636070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Centre Hospitalier Universitaire de N\u00eemes","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Alopecia represents a multifaceted challenge with distinct etiologies and consequences. Transposed to the world of oncology, different types of alopecia and molecular pathways have been characterized, allowing a better understanding of the underlying mechanisms. In patients with cancer, alopecia can be iatrogenic (i.e., due to conventional chemotherapies, endocrine therapies, targeted therapies, immunotherapies, radiotherapy and surgery) or a direct consequence of the disease itself (e.g., malnutrition, scalp metastases and paraneoplastic syndromes). Identification of the actual incriminated mechanism(s) is therefore essential in order to deliver appropriate supportive care, whether preventive or curative. On the preventive side, the last few years have seen the advent of the automated cooling cap, a prophylactic approach supported by several randomized clinical trials. On the curative side, although the treatments currently available are limited, several promising therapeutic approaches are under development. Appropriate alopecia management is essential, particularly regarding its psychological repercussions with significant consequences on the quality of life of patients and their family and with a potential impact on treatment compliance.<\/jats:p>","DOI":"10.3390\/cancers13215556","type":"journal-article","created":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T10:33:09Z","timestamp":1636108389000},"page":"5556","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Cancer-Related Alopecia: From Etiologies to Global Management"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6338-9306","authenticated-orcid":false,"given":"Stanislas","family":"Quesada","sequence":"first","affiliation":[{"name":"Institut R\u00e9gional du Cancer de Montpellier, 34090 Montpellier, France"},{"name":"Medical Oncology Department, University Hospital, 30900 N\u00eemes, France"},{"name":"Faculty of Medicine, University of Montpellier, 34090 Montpellier, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1034-8815","authenticated-orcid":false,"given":"Alexandre","family":"Guichard","sequence":"additional","affiliation":[{"name":"Legacy Healthcare Switzerland SA, 1066 Epalinges, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Fiteni","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, University Hospital, 30900 N\u00eemes, France"},{"name":"Faculty of Medicine, University of Montpellier, 34090 Montpellier, France"},{"name":"UMR INSERM IDESP\u2014Desbrest Institute of Epidemiology and Public Health, University of Montpellier, 34090 Montpellier, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,5]]},"reference":[{"key":"ref_1","unstructured":"Blume-Peytavi, U. (2008). Hair Growth and Disorders, Springer."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/annonc\/mdt476","article-title":"Development and Validation of Chemotherapy-Induced Alopecia Distress Scale (CADS) for Breast Cancer Patients","volume":"25","author":"Cho","year":"2014","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1200\/JCO.2000.18.4.754","article-title":"High-Dose Sequential Chemotherapy with Recombinant Granulocyte Colony-Stimulating Factor and Repeated Stem-Cell Support for Inflammatory Breast Cancer Patients: Does Impact on Quality of Life Jeopardize Feasibility and Acceptability of Treatment?","volume":"18","author":"Viens","year":"2000","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/cncr.10630","article-title":"Changing Patient Perceptions of the Side Effects of Cancer Chemotherapy","volume":"95","author":"Carelle","year":"2002","journal-title":"Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ejon.2007.10.002","article-title":"The Impact of Cancer and Chemotherapy: Perceptual Similarities and Differences between Cancer Patients, Nurses and Physicians","volume":"12","author":"Mulders","year":"2008","journal-title":"Eur. J. Oncol. Nurs. Off. J. Eur. Oncol. Nurs. Soc."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s10549-015-3502-4","article-title":"Quantitative Changes in Skin Composition Parameters Due to Chemotherapy in Breast Cancer Patients: A Cohort Study","volume":"152","author":"Kang","year":"2015","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/jamadermatol.2020.2127","article-title":"Assessment and Treatment Outcomes of Persistent Radiation-Induced Alopecia in Patients with Cancer","volume":"156","author":"Phillips","year":"2020","journal-title":"JAMA Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1001\/jamadermatol.2018.0454","article-title":"Endocrine Therapy-Induced Alopecia in Patients with Breast Cancer","volume":"154","author":"Shapiro","year":"2018","journal-title":"JAMA Dermatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1634\/theoncologist.2013-0193","article-title":"Alopecia with Endocrine Therapies in Patients with Cancer","volume":"18","author":"Saggar","year":"2013","journal-title":"Oncologist"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jaad.2018.03.055","article-title":"Hair Disorders in Patients with Cancer","volume":"80","author":"Shapiro","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.jaad.2018.03.056","article-title":"Hair Disorders in Cancer Survivors","volume":"80","author":"Shapiro","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1053\/j.seminoncol.2012.01.009","article-title":"Advances in the Management of Cutaneous Toxicities of Targeted Therapies","volume":"39","author":"Robert","year":"2012","journal-title":"Semin. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40257-018-0384-3","article-title":"Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails","volume":"19","author":"Lacouture","year":"2018","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1093\/annonc\/mdv390","article-title":"Alopecia in Patients Treated with Molecularly Targeted Anticancer Therapies","volume":"26","author":"Belum","year":"2015","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Guichard, A., and Fanian, F. (2016). Agache\u2019s Measuring the Skin: Non-Invasive Investigations, Physiology, Normal Constants, Springer. Hair Trichogram.","DOI":"10.1007\/978-3-319-32383-1_110"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Olver, I. (2011). Chemotherapy-Induced Alopecia: Overview and Methodology for Characterizing Hair Changes and Regrowth. The MASCC Textbook of Cancer Supportive Care and Survivorship, Springer.","DOI":"10.1007\/978-1-4419-1225-1"},{"key":"ref_17","unstructured":"National Institutes of Health, and National Cancer Institute (2021, June 01). Common Terminology Criteria for Adverse Events (CTCAE), Version 5.0, Available online: https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/ctcae_v5_quick_reference_5x7.pdf."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s001050051293","article-title":"[Hairdex: A tool for evaluation of disease-specific quality of life in patients with hair diseases]","volume":"52","author":"Fischer","year":"2001","journal-title":"Der Hautarzt"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.annonc.2019.10.027","article-title":"An International Update of the EORTC Questionnaire for Assessing Quality of Life in Breast Cancer Patients: EORTC QLQ-BR45","volume":"31","author":"Cardoso","year":"2020","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1001\/jamadermatol.2018.5071","article-title":"Assessment of Quality of Life and Treatment Outcomes of Patients with Persistent Postchemotherapy Alopecia","volume":"155","author":"Chan","year":"2019","journal-title":"JAMA Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/S1470-2045(12)70553-3","article-title":"Pathobiology of Chemotherapy-Induced Hair Loss","volume":"14","author":"Paus","year":"2013","journal-title":"Lancet Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000102025","article-title":"Chemotherapy-Induced Anagen Effluvium: Diffuse or Patterned?","volume":"215","year":"2007","journal-title":"Dermatology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jaad.2018.04.046","article-title":"Cutaneous Toxicity as a Predictive Biomarker for Clinical Outcome in Patients Receiving Anticancer Therapy","volume":"79","author":"Rzepecki","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"R81","DOI":"10.1186\/bcr3475","article-title":"A Genome-Wide Association Study of Chemotherapy-Induced Alopecia in Breast Cancer Patients","volume":"15","author":"Chung","year":"2013","journal-title":"Breast Cancer Res. BCR"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jaad.2009.06.063","article-title":"Permanent Chemotherapy-Induced Alopecia: Case Report and Review of the Literature","volume":"63","author":"Tallon","year":"2010","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_26","first-page":"43","article-title":"Busulphan\/Cyclophosphamide Conditioning for Bone Marrow Transplantation May Lead to Failure of Hair Regrowth","volume":"7","author":"Baker","year":"1991","journal-title":"Bone Marrow Transplant."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1365-2133.2009.09043.x","article-title":"Irreversible and Severe Alopecia Following Docetaxel or Paclitaxel Cytotoxic Therapy for Breast Cancer","volume":"160","author":"Prevezas","year":"2009","journal-title":"Br. J. Dermatol."},{"key":"ref_28","first-page":"2887","article-title":"Permanent Chemotherapy-Induced Alopecia: Awareness and Attitudes among Health Care Providers","volume":"28","author":"Stoehr","year":"2020","journal-title":"Support. Care Cancer Off. J. Multinatl. Assoc. Support. Care Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1634\/theoncologist.2018-0184","article-title":"Permanent Chemotherapy-Induced Alopecia in Patients with Breast Cancer: A 3-Year Prospective Cohort Study","volume":"24","author":"Kang","year":"2019","journal-title":"Oncologist"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/annonc\/mds095","article-title":"Permanent Scalp Alopecia Related to Breast Cancer Chemotherapy by Sequential Fluorouracil\/Epirubicin\/Cyclophosphamide (FEC) and Docetaxel: A Prospective Study of 20 Patients","volume":"23","author":"Kluger","year":"2012","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1001\/jamadermatol.2020.1867","article-title":"Association Between ABCB1 Genetic Variants and Persistent Chemotherapy-Induced Alopecia in Women with Breast Cancer","volume":"156","author":"Pita","year":"2020","journal-title":"JAMA Dermatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/bmt.2017.15","article-title":"Permanent Diffuse Alopecia after Haematopoietic Stem Cell Transplantation in Childhood","volume":"52","author":"Bresters","year":"2017","journal-title":"Bone Marrow Transplant."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.jaad.2018.07.004","article-title":"Efficacy, Safety, and Comparison of Sonic Hedgehog Inhibitors in Basal Cell Carcinomas: A Systematic Review and Meta-Analysis","volume":"79","author":"Xie","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1111\/bjd.13630","article-title":"Persistent Alopecia Induced by Vismodegib","volume":"172","author":"Alkeraye","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Peng, C., and Lei, J.-X. (2020). The Incidence and Risk of Cutaneous Toxicities Associated with Dabrafenib in Melanoma Patients: A Systematic Review and Meta-Analysis. Eur. J. Hosp. Pharm. Sci. Pract.","DOI":"10.1136\/ejhpharm-2020-002347"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/annonc\/mds237","article-title":"An Open-Label, Multicenter, Phase II Study of Bevacizumab for the Treatment of Angiosarcoma and Epithelioid Hemangioendotheliomas","volume":"24","author":"Agulnik","year":"2013","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.adengl.2019.02.017","article-title":"Adverse Hair Reactions to New Targeted Therapies for Cancer","volume":"110","year":"2019","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10549-013-2744-2","article-title":"Aromatase Inhibitor Therapy and Hair Loss among Breast Cancer Survivors","volume":"142","author":"Gallicchio","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.7326\/0003-4819-134-12-200106190-00029","article-title":"Tamoxifen-Induced Total Alopecia","volume":"134","author":"Puglisi","year":"2001","journal-title":"Ann. Intern. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"469","DOI":"10.5301\/tj.5000376","article-title":"Adjuvant Aromatase Inhibitor Therapy in Early Breast Cancer: What Factors Lead Patients to Discontinue Treatment?","volume":"101","author":"Moscetti","year":"2015","journal-title":"Tumori"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1080\/14737140.2017.1355242","article-title":"Fatigue, Alopecia and Stomatitis among Patients with Breast Cancer Receiving Cyclin-Dependent Kinase 4 and 6 Inhibitors: A Systematic Review and Meta-Analysis","volume":"17","author":"Lasheen","year":"2017","journal-title":"Expert Rev. Anticancer Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s10549-017-4523-y","article-title":"Ribociclib with Letrozole vs Letrozole Alone in Elderly Patients with Hormone Receptor-Positive, HER2-Negative Breast Cancer in the Randomized MONALEESA-2 Trial","volume":"167","author":"Sonke","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_43","unstructured":"Halperin, E.C. (2019). Perez & Brady\u2019s Principles and Practice of Radiation Oncology, Wolters Kluwer."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.ijrobp.2004.04.031","article-title":"Permanent Alopecia after Cranial Irradiation: Dose\u2013Response Relationship","volume":"60","author":"Lawenda","year":"2004","journal-title":"Int. J. Radiat. Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13014-014-0220-8","article-title":"Evaluation of Permanent Alopecia in Pediatric Medulloblastoma Patients Treated with Proton Radiation","volume":"9","author":"Min","year":"2014","journal-title":"Radiat. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41571-019-0218-0","article-title":"Adverse Effects of Immune-Checkpoint Inhibitors: Epidemiology, Management and Surveillance","volume":"16","author":"Martins","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1111\/bjd.15237","article-title":"Immune-Related Alopecia (Areata and Universalis) in Cancer Patients Receiving Immune Checkpoint Inhibitors","volume":"176","author":"Zarbo","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fonc.2020.00091","article-title":"Potential Immune-Related Adverse Events Associated with Monotherapy and Combination Therapy of Ipilimumab, Nivolumab, and Pembrolizumab for Advanced Melanoma: A Systematic Review and Meta-Analysis","volume":"10","author":"Almutairi","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e14171","DOI":"10.1111\/dth.14171","article-title":"Alopecia Areata as an Immune-Related Adverse Event of Immune Checkpoint Inhibitors: A Review","volume":"33","author":"Antoury","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jdcr.2018.05.022","article-title":"Nivolumab-Induced Alopecia Areata: A Reversible Factor of Good Prognosis?","volume":"4","author":"Lakhmiri","year":"2018","journal-title":"JAAD Case Rep."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Simonaggio, A., Michot, J.M., Voisin, A.L., Le Pavec, J., Collins, M., Lallart, A., Cengizalp, G., Vozy, A., Laparra, A., and Varga, A. (2019). Evaluation of Readministration of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients with Cancer. JAMA Oncol.","DOI":"10.1001\/jamaoncol.2019.1022"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s40257-017-0336-3","article-title":"Dermatologic Reactions to Immune Checkpoint Inhibitors: Skin Toxicities and Immunotherapy","volume":"19","author":"Sibaud","year":"2018","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.nupar.2012.10.002","article-title":"Nutrition chez le patient adulte atteint de cancer: Textes courts","volume":"26","author":"Senesse","year":"2012","journal-title":"Nutrition Clinique et M\u00e9tabolisme"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Guo, E.L., and Katta, R. (2017). Diet and Hair Loss: Effects of Nutrient Deficiency and Supplement Use. Dermatol. Pract. Concept., 1\u201310.","DOI":"10.5826\/dpc.0701a01"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"624","DOI":"10.5021\/ad.2014.26.5.624","article-title":"Alopecia Neoplastica Due to Gastric Adenocarcinoma Metastasis to the Scalp, Presenting as Alopecia: A Case Report and Literature Review","volume":"26","author":"Kim","year":"2014","journal-title":"Ann. Dermatol."},{"key":"ref_56","first-page":"bcr2012006217","article-title":"Alopecia: A Common Paraneoplastic Manifestation of Cholangiocarcinoma in Humans and Animals","volume":"2012","author":"Antoniou","year":"2012","journal-title":"Case Rep."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jns.2011.05.038","article-title":"Multiple Paraneoplastic Syndromes: Myasthenia Gravis, Vitiligo, Alopecia Areata, and Oral Lichen Planus Associated with Thymoma","volume":"308","author":"Qiao","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3325\/cmj.2016.57.229","article-title":"High Frequency of Cutaneous Manifestations Including Vitiligo and Alopecia Areata in a Prospective Cohort of Patients with Chronic Graft-vs-Host Disease","volume":"57","author":"Desnica","year":"2016","journal-title":"Croat. Med. J."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.annonc.2020.11.005","article-title":"Prevention and Management of Dermatological Toxicities Related to Anticancer Agents: ESMO Clinical Practice Guidelines","volume":"32","author":"Lacouture","year":"2020","journal-title":"Ann. Oncol."},{"key":"ref_60","first-page":"2565","article-title":"Efficacy and Tolerability of Two Scalp Cooling Systems for the Prevention of Alopecia Associated with Docetaxel Treatment","volume":"21","author":"Betticher","year":"2013","journal-title":"Support. Care Cancer Off. J. Multinatl. Assoc. Support. Care Cancer"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1188\/17.CJON.226-233","article-title":"Scalp Cooling: A Literature Review of Efficacy, Safety, and Tolerability for Chemotherapy-Induced Alopecia","volume":"21","author":"Ross","year":"2017","journal-title":"Clin. J. Oncol. Nurs."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1001\/jama.2016.21038","article-title":"Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer","volume":"317","author":"Rugo","year":"2017","journal-title":"JAMA"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1001\/jama.2016.20939","article-title":"Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial","volume":"317","author":"Nangia","year":"2017","journal-title":"JAMA"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10549-017-4185-9","article-title":"Scalp Cooling with Adjuvant\/Neoadjuvant Chemotherapy for Breast Cancer and the Risk of Scalp Metastases: Systematic Review and Meta-Analysis","volume":"163","author":"Rugo","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.clbc.2017.07.012","article-title":"Scalp Hypothermia for Preventing Alopecia During Chemotherapy. A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"18","author":"Rugo","year":"2018","journal-title":"Clin. Breast Cancer"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Zhou, T., Han, S., Zhu, Z., Hu, Y., and Xing, W. (2020). Interventions for Preventing Chemotherapy-Induced Alopecia: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. Cancer Nurs.","DOI":"10.1097\/NCC.0000000000000899"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.abd.2020.03.005","article-title":"Scalp Cooling to Prevent Chemotherapy-Induced Alopecia","volume":"95","author":"Silva","year":"2020","journal-title":"An. Bras. Dermatol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0190-9622(96)90500-9","article-title":"A Randomized Trial of Minoxidil in Chemotherapy-Induced Alopecia","volume":"35","author":"Duvic","year":"1996","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10549-018-4996-3","article-title":"Safety of 5\u03b1-Reductase Inhibitors and Spironolactone in Breast Cancer Patients Receiving Endocrine Therapies","volume":"174","author":"Rozner","year":"2019","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/13543784.2017.1303480","article-title":"Bimatoprost for the Treatment of Eyelash, Eyebrow and Scalp Alopecia","volume":"26","author":"Tosti","year":"2017","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Bouhanna, P., Larif, M., and Guichard, A. (2020). Hair Transplantation in Endocrine Therapy\u2013Induced Alopecia. Dermatol. Surg., publish ahead of print.","DOI":"10.1097\/DSS.0000000000002459"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/pbc.20689","article-title":"Surgical Interventions for the Treatment of Radiation-Induced Alopecia in Pediatric Practice","volume":"49","author":"Graham","year":"2007","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1634\/theoncologist.2017-0263","article-title":"A Clinical and Biological Guide for Understanding Chemotherapy-Induced Alopecia and Its Prevention","volume":"23","author":"Dunnill","year":"2018","journal-title":"Oncologist"},{"key":"ref_74","unstructured":"Clinicaltrials.Gov (2021, June 01). Database, Available online: https:\/\/clinicaltrials.gov\/ct2\/results?cond=Cancer+Alopecia&term=&cntry=&state=&city=&dist=."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/sctm.19-0301","article-title":"Tissue Engineering Strategies for Human Hair Follicle Regeneration: How Far from a Hairy Goal?","volume":"9","author":"Castro","year":"2020","journal-title":"Stem Cells Transl. Med."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/21\/5556\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:26:32Z","timestamp":1760167592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/21\/5556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,5]]},"references-count":75,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["cancers13215556"],"URL":"https:\/\/doi.org\/10.3390\/cancers13215556","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,5]]}}}